πŸ‡ΊπŸ‡Έ FDA
Patent

US 11866411

Therapeutic compounds and compositions

granted A61KA61K31/497A61K31/5513

Quick answer

US patent 11866411 (Therapeutic compounds and compositions) held by Agios Pharmaceuticals, Inc. expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/497, A61K31/5513, A61P, A61P35/00